Evidence map›Paper›PMID 40879304›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2025

GAA-FGF14 Expansions and CACNA1A Variants: Phenotypic Overlap and Diagnostic Implications.

Elisabetta Indelicato, Zofia Fleszar, David Pellerin, Wolfgang Nachbauer, Stephan Zuchner, Andreas Traschütz, Matthias Amprosi, Ludger Schöls, Tobias B Haack, Bernard Brais and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elisabetta IndelicatoCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.ORCID https://orcid.org/0000-0003-0217-8630
Zofia FleszarDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
David PellerinDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Wolfgang NachbauerCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Stephan ZuchnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Andreas TraschützGerman Center for Neurodegenerative Diseases, Tübingen, Germany.ORCID https://orcid.org/0000-0002-8165-5898
Matthias AmprosiCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Ludger SchölsDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Sylvia BoeschCenter for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
Matthis SynofzikGerman Center for Neurodegenerative Diseases, Tübingen, Germany.ORCID https://orcid.org/0000-0002-2280-7273

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn intronic (GAA)•(TTC) repeat expansion in FGF14 was recently identified as the cause of spinocerebellar ataxia 27B (SCA27B), a disorder presenting with both chronic cerebellar ataxia and episodic symptoms. The phenotype of SCA27B overlaps with that of CACNA1A spectrum disorders.

objectiveThe objective of this work was to investigate the prevalence of GAA-FGF14 repeat expansions in patients with ataxia so far considered to be related to underlying CACNA1A variants.

methodsThis is a cross-sectional multicenter study.

resultsGAA-FGF14 testing showed pathogenic expansions (≥250 repeats) in 6/67 (9%) patients carrying CACNA1A variants. All patients with a pathogenic GAA-FGF14 expansion had a disease onset >40 years and carried variants of uncertain significance (VUSs) in CACNA1A. Genetic reevaluation led to the reclassification of CACNA1A VUSs as likely benign in four of six patients, who were ultimately diagnosed with SCA27B.

conclusionsLate-onset ataxia cases previously considered as CACNA1A-related disorder should be reevaluated and tested for SCA27B, particularly if related to a VUS in CACNA1A. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Calcium ChannelsFibroblast Growth FactorsSpinocerebellar AtaxiasAdultAgedCalcium Channels, N-TypeCross-Sectional StudiesFemaleHumansMaleMiddle AgedPhenotypeCACNA1A protein, humanCalcium ChannelsCalcium Channels, N-Typefibroblast growth factor 14Fibroblast Growth FactorsCACNA1Aepisodic ataxiaGAA‐FGF14 ataxiaSCA27Bspinocerebellar ataxia 27B

Identifiers

PMID40879304
PMCPMC12553994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.